about
Genomic responses in rat cerebral cortex after traumatic brain injury.Update on Inflammatory Biomarkers and Treatments in Ischemic StrokePolyinosinic-polycytidylic acid has therapeutic effects against cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via TLR3Osteocalcin- and osteopontin-containing neurons in the rat hind brainOsteopontin is not critical for otoconia formation or balance function.Baifuzi reduces transient ischemic brain damage through an interaction with the STREX domain of BKCa channels.Osteopontin reduced hypoxia-ischemia neonatal brain injury by suppression of apoptosis in a rat pup model.Protective effects of recombinant osteopontin on early brain injury after subarachnoid hemorrhage in ratsCharacterization of osteopontin expression and function after status epilepticusProgressive secondary neurodegeneration and microcalcification co-occur in osteopontin-deficient mice.Osteopontin and fibronectin levels are decreased in vitreous of autoimmune uveitis and retinal expression of both proteins indicates ECM re-modeling.Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3Recombinant osteopontin in cerebral vasospasm after subarachnoid hemorrhageRapid degradation of Bim by the ubiquitin-proteasome pathway mediates short-term ischemic tolerance in cultured neurons.The endotoxin-induced neuroinflammation model of Parkinson's disease.Identification of potentially neuroprotective genes upregulated by neurotrophin treatment of CA3 neurons in the injured brain.The effect of osteopontin and osteopontin-derived peptides on preterm brain injuryOsteopontin is induced by TGF-β2 and regulates metabolic cell activity in cultured human optic nerve head astrocytes.LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury.Osteopontin mediates survival, proliferation and migration of neural stem cells through the chemokine receptor CXCR4.Sustained expression of osteopontin is closely associated with calcium deposits in the rat hippocampus after transient forebrain ischemia.Spatiotemporal expression of osteopontin in the striatum of rats subjected to the mitochondrial toxin 3-nitropropionic acid correlates with microcalcification.Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke.Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localizationRecombinant Osteopontin Stabilizes Smooth Muscle Cell Phenotype via Integrin Receptor/Integrin-Linked Kinase/Rac-1 Pathway After Subarachnoid Hemorrhage in Rats.The P2X4 receptor is required for neuroprotection via ischemic preconditioningIncreased Expression of Osteopontin in Retinal Degeneration Induced by Blue Light-Emitting Diode Exposure in MiceThe inflammatory response in acyl-CoA oxidase 1 deficiency (pseudoneonatal adrenoleukodystrophy)Sumo-2/3-ylation following in vitro modeled ischemia is reduced in delayed ischemic tolerance.In Vitro Effects of Lead on Gene Expression in Neural Stem Cells and Associations between Up-regulated Genes and Cognitive Scores in Children.Cellular and molecular determinants of stroke-induced changes in subventricular zone cell migrationPerlecan domain V therapy for stroke: a beacon of hope?Proregenerative properties of ECM molecules.A research update on the potential roles of aquaporin 4 in neuroinflammation.Intranasal gene delivery for treating Parkinson's disease: overcoming the blood-brain barrier.Blood-brain barrier damage in vascular dementia.CD44 Splice Variants as Potential Players in Alzheimer's Disease Pathology.Bisperoxovandium (pyridin-2-squaramide) targets both PTEN and ERK1/2 to confer neuroprotection.Osteopontin alters the functional profile of porcine microglia in vitro.Inflammation modulates expression of laminin in the central nervous system following ischemic injury.
P2860
Q24816314-5E56CFC3-42BD-4E61-A01C-73D31B762604Q28078744-3D9B88C3-FCD5-42DF-BF15-416451DB424BQ28238114-1D9DE9DB-172E-416D-B59D-8FAD007F3E53Q28566147-B629265B-AAE5-482A-81BA-7518C361AF91Q30489364-A2FC13B5-6EB4-45EC-A064-08393E61B884Q30498186-4B1E637D-C0AB-4FCE-82CD-BE3AB1AD5EBFQ30498262-EE782AA7-1540-489C-BD95-B33356358838Q33598845-5A7F5923-76F5-4B46-A516-BFC0850ADD0EQ33877307-F6D823E1-C6FC-4A78-B432-3000AD56877BQ34033518-D63CB4F1-1B2F-47F1-9C33-8DC7B9BB7B00Q34109881-22DA5705-8303-4E91-A053-D8AC2AAEC44EQ34160637-61CAA933-C047-408C-87FC-1AE1A154F82AQ34257955-5E6A5486-A17A-4E73-8E91-191554CC2196Q34446404-5BB45E31-DCD0-4FCC-9A0A-195DB1999310Q34557246-194BAB78-D243-47C6-BBB2-C356662ADE01Q34671447-26A65AEA-27C4-41A8-A8A1-F6EDE9734F05Q34706705-C27B4C81-360F-47AE-BFF1-0A2EB92418D3Q35144030-ECA27B6E-DC98-4684-9615-34B79A2064D0Q35555026-C569784B-A8E5-4FA3-9AA3-1FF6ABE97E74Q35727350-AC9738C6-4721-4DEC-BA7C-3508F2DF111FQ36285877-A24F6EE9-9620-4F09-94A0-186960A608F1Q36323553-D9EACF72-320A-41B5-8CF5-67B1E654503AQ36351793-6D6B6FC6-9315-4CC5-B9C5-B2B28C2E1724Q36578825-131ED325-BD95-4287-B117-20AB75869BBBQ36840139-3085D163-D0D5-4BD7-AA8C-7B98948FD34DQ36897581-1597AFCF-DAF4-40E4-8BC5-095582277B1FQ37121011-85E9BED1-FB52-4986-9A69-8FA26C7EA105Q37217534-969B09DC-D136-474B-A6A8-6184EB01B473Q37415135-16ECC978-626B-47C2-87A0-5F28C8E84A7CQ37738912-854CDB83-AC0D-4E8F-924F-40FB29FCEFAFQ37776731-B31E4876-0C55-41C4-88F0-7529B7ADBFE2Q38091111-9D329561-8F97-49BD-857D-2F181670BCFEQ38160233-A6C480CD-DB4F-4DE0-8EEC-6217CD073652Q38563837-6C0DE629-B3BA-4945-AE06-D106F80B3FBAQ38569775-C4D2315E-9023-4542-B1DE-8ACBD633DA8AQ38647755-2CAB3B35-573A-40C7-929B-4DC5EF59DB0CQ38760659-87A25644-8A54-4ABC-95DF-D2887CB69483Q38996097-2D261F93-2222-4F45-AFC9-92685602C910Q39279720-81C2F73F-2E56-4234-AAAA-70B7594BCFFAQ39320621-D277A353-36E1-4339-BC8B-95967DB242A2
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Neuroprotection by osteopontin in stroke.
@en
Neuroprotection by osteopontin in stroke.
@nl
type
label
Neuroprotection by osteopontin in stroke.
@en
Neuroprotection by osteopontin in stroke.
@nl
prefLabel
Neuroprotection by osteopontin in stroke.
@en
Neuroprotection by osteopontin in stroke.
@nl
P2093
P356
P1476
Neuroprotection by osteopontin in stroke.
@en
P2093
Holly Rosenzweig
Jennifer A Cameron
Kristian Doyle
Manabu Minami
Mary P Stenzel-Poore
Nikola S Lessov
Robert Meller
Roger P Simon
Sonya King
Susan L Stevens
P304
P356
10.1038/SJ.JCBFM.9600022
P577
2005-02-01T00:00:00Z